← Leaderboards
Aaron R. Hawkins
Liquilume Diagnostics, Inc.
$1,176,029
Attributed
$5,698,743
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2012–19$2M$1.5M$1M$500K$0
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$5,698,743 · 2
By mechanism
R01$5,426,638 · 1
R43$272,105 · 1
Top collaborators
- Holger Schmidt6 shared
- William G Pitt5 shared
- Richard A Robison5 shared
- Adam Thomas Woolley5 shared
- Philip Measor1 shared
Most similar at Liquilume Diagnostics, Inc.
Same institution · by research overlap
- Philip Measor$90,702
Others in their field
Top investigators on “Single Molecule”
- Alfred G Gilman · University Of Texas Sw Med Ctr/Dallas$62,461,926
- Stuart L Schreiber · Harvard University (Medical School)$53,513,514
- Stephen K Burley · Rutgers University New Brunswick$49,350,740
- George M Church · Harvard University (Medical School)$42,200,460
- David Heimbrook · Leidos Biomedical Research, Inc.$42,135,568
- Huw M Davies · Suny At Buffalo$40,635,696
Research focus
Single MoleculeMicrofluidicsSamplingTechnologyNucleic AcidsFda ApprovedMolecularPharmaceutical PreparationsCellsBaseDetectionPathogenBlood FiltrationBlood CirculationBacteremiaBloodAntibioticsDevicesCarbapenemaseAntibiotic ResistanceBacterial ResistanceCarbapenem-Resistant EnterobacteriaceaeCytolysisDiagnosis
Grant awards (6)
Multiplexed, Non-Amplified, Nucleic Acid-Based Identification of Multidrug Resistant Pathogens Using an Integrated Optofluidic Platform$982,407
R01 · FY2019 · AI · contact PI
Multiplexed, Non-Amplified, Nucleic Acid-Based Identification of Multidrug Resistant Pathogens Using an Integrated Optofluidic Platform$988,510
R01 · FY2018 · AI · contact PI
Multiplexed, Non-Amplified, Nucleic Acid-Based Identification of Multidrug Resistant Pathogens Using an Integrated Optofluidic Platform$1,002,828
R01 · FY2017 · AI · contact PI
Multiplexed, Non-Amplified, Nucleic Acid-Based Identification of Multidrug Resistant Pathogens Using an Integrated Optofluidic Platform$1,069,803
R01 · FY2016 · AI · contact PI
Multiplexed, Non-Amplified, Nucleic Acid-Based Identification of Multidrug Resistant Pathogens Using an Integrated Optofluidic Platform$1,383,090
R01 · FY2015 · AI · contact PI
Rapid, low-cost mRNA analysis system for cancer companion diagnostics$272,105
R43 · FY2012 · TR